Total Payments
$3,633
2024 Payments
$598.34
Companies
21
Transactions
209
Medicare Patients
1,058
Medicare Billing
$99,894
Payment Breakdown by Category
Food & Beverage$3,622 (99.7%)
Education$11.56 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,622 | 208 | 99.7% |
| Education | $11.56 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $629.35 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $584.93 | 29 | $0 (2024) |
| Novo Nordisk Inc | $457.20 | 28 | $0 (2024) |
| Amgen Inc. | $358.43 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $244.45 | 14 | $0 (2023) |
| Exact Sciences Corporation | $229.84 | 10 | $0 (2024) |
| ABBVIE INC. | $184.21 | 10 | $0 (2024) |
| PFIZER INC. | $167.21 | 9 | $0 (2023) |
| Merck Sharp & Dohme LLC | $162.48 | 10 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $102.47 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $598.34 | 32 | Lilly USA, LLC ($134.38) |
| 2023 | $1,361 | 76 | Novo Nordisk Inc ($199.03) |
| 2022 | $520.11 | 29 | AstraZeneca Pharmaceuticals LP ($118.89) |
| 2021 | $1,154 | 72 | Lilly USA, LLC ($270.14) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Inflammation | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Oncology | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 579 | 854 | $189,871 | $50,385 |
| 2022 | 7 | 361 | 599 | $131,500 | $36,832 |
| 2021 | 1 | 97 | 97 | $32,218 | $10,664 |
| 2020 | 1 | 21 | 21 | $5,250 | $2,012 |
Total Patients
1,058
Total Services
1,571
Medicare Billing
$99,894
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 387 | $98,685 | $22,252 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 133 | 133 | $44,289 | $13,921 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 218 | $39,240 | $10,323 | 26.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 29 | $1,508 | $1,478 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $1,640 | $1,178 | 71.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 35 | $3,885 | $970.56 | 25.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 12 | 12 | $624.00 | $262.80 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 365 | $93,075 | $25,365 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 93 | $16,740 | $4,643 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $10,989 | $3,386 | 30.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 30 | $5,400 | $1,333 | 24.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 33 | $3,663 | $997.47 | 27.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,025 | $707.25 | 69.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 20 | 20 | $608.00 | $400.71 | 65.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 97 | 97 | $32,218 | $10,664 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $5,250 | $2,012 | 38.3% |
About Danielle Gregoire, PA-C
Danielle Gregoire, PA-C is a Medical healthcare provider based in Bradford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639261977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Danielle Gregoire, PA-C has received a total of $3,633 in payments from pharmaceutical and medical device companies, with $598.34 received in 2024. These payments were reported across 209 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,622).
As a Medicare-enrolled provider, Gregoire has provided services to 1,058 Medicare beneficiaries, totaling 1,571 services with total Medicare billing of $99,894. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Bradford, PA
- Active Since 09/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1639261977
Products in Payments
- MOUNJARO (Drug) $273.54
- TRINTELLIX (Drug) $244.45
- Otezla (Drug) $239.48
- Cologuard Collection Kit (Device) $229.84
- FARXIGA (Drug) $218.59
- Ozempic (Drug) $216.79
- EMGALITY (Drug) $203.24
- BREZTRI (Drug) $200.61
- JARDIANCE (Drug) $148.09
- Rybelsus (Drug) $147.25
- NURTEC ODT (Drug) $142.80
- JANUVIA (Drug) $106.17
- UBRELVY (Drug) $90.20
- EVENITY (Biological) $87.00
- AIRSUPRA (Drug) $79.10
- GVOKE HYPOPEN (Drug) $78.46
- FREESTYLE LIBRE 2 (Device) $67.15
- COMIRNATY (Biological) $61.40
- STIOLTO RESPIMAT (Drug) $59.51
- TRELEGY ELLIPTA (Drug) $54.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.